By Alba Fishta
Rate: (6 Ratings)
Public Health (PH) and Genetics are often considered as two independent subjects of health care. PH looks simultaneously at the control of epidemiological diseases and malnutrition in community-based populations which is a problem predominantly in developing countries. Meanwhile, in developed countries the increasing incidence of diseases such as cancer, diabetes etc. is considered a critical problem. While Genetics deals with the micro-level of health, PH looks at populations at a macro-level. However, both aim improving the quality of health and decreasing the morbidity and mortality. Methods: Public Health Genetics (PHG) programs should be proposed and applied for each country. Analysing of PH and Genetics’ data, identifies the diseases with highest incidence, possible causal or contributing factors, the aetiology and history of the diseases, relevant treatment protocols as well as cost of tests and therapies. Evidence-based results will suggest innovative preventive programs based on recent genetic findings. Important is the costs-analyse each disease-management, whereby the country-specific legal and ethical influences should not be overlooked. Country-based PHG strategies with innovative disease-management protocols should be proposed. Discussion: PHG will propose innovative disease-management schemata. Application of cost-effective mechanisms will be possible; consequently, the population at risk will be identified and offered to undergo genetic screening tests, vaccination or therapy. Educational programs about PHG for the public and health professionals will change the health behaviour of people at risk and will provide them latest treatment by health professionals. Therefore, more diseases will be prevented and lower global mortality will be achieved.